Article Text

PDF
FRI0474 International Classification of Functioning, Disability, and Health (ICF) Core Sets for Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) and Idiopathic Pulmonary Fibrosis (IPF) – A Necessary Map to Health Care Provision in the ERA of ICD-11
  1. L.A. Saketkoo1,
  2. R. Escorpizo2,3,
  3. K.J. Keen4,5,
  4. K. Fligelstone6,7,
  5. S.S. Birring8,
  6. M.R. Lammi9,
  7. J.A. Lasky1,
  8. D.R. LeSage10,
  9. E. Renzoni11,
  10. A.M. Russell11,
  11. C. Sarver12,
  12. M.B. Scholand13,
  13. J. Varga14,
  14. O. Distler15
  1. 1Tulane Lung Center, UMC Scleroderma and Sarcoidosis Patient Care and Research Center, Tulane University Health Sciences Center, New Orleans, United States
  2. 2ICF Unit, Swiss Paraplegic Research, Nottwil, Switzerland
  3. 3Department of Rehabilitation and Movement Science, University of Vermont, Burlington, VT, United States
  4. 4Department of Mathematics and Statistics
  5. 5Health Research Institute, University of Northern British Columbia, British Columbia, Canada
  6. 6Scleroderma Society UK
  7. 7Scleroderma Unit, Royal Free Hospital
  8. 8Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom
  9. 9Pulmonary Medicine, LSU Health Sciences Center
  10. 10Louisiana Office of Public Health, New Orleans, United States
  11. 11National Heart Lung Blood Institute, Royal Brompton Hospital, London, United Kingdom
  12. 12Patient Research Partner, Maryland
  13. 13Pulmonary Medicine, University of Utah, Salt Lake City, United States
  14. 14National Koranyi Institute for TB and Pulmonology, Budapest, Hungary
  15. 15Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland

Abstract

Background A recent consensus project (Saketkoo et al, Thorax 2014) recommended a minimum core set of outcome measures for use in future clinical trials of CTD-ILD and IPF. The World Health Organization (WHO) introduced the International Classification of Functioning, Disability, and Health (ICF) as a scientific method of disability data collection and a universal framework of >1200 categories describing disability in terms of the bio-psycho-social model with consideration of environmental and personal factors. For accurate representation of disease, ease of healthcare provision and fair allocation of resources, it is essential that ICF Core Sets be established for rare and complex diseases.

Methods Per updated ICF linkage rules, each instrument from the published CTD-ILD and IPF core sets were deconstructed to meaningful concepts and independently linked by 2 health professionals experienced in ICF linkage (RE, LAS). Inter-linker agreement on independent linkages was analyzed (KK). A 3rd linker (OD) arbitrated if irreconcilable linkages occurred.

Results Eighty-two ICF categories were identified under the 4 ICF domains for 6 patient questionnaires and 3 traditional objective measures. The proportion of agreement ranged from 0.79 (95% CI: 0.62, 0.91) to 0.93 (0.76, 0.99) (Table 1) with the overall proportion of inter-linker agreement 0.86 (0.82, 0.89). 20 new “Personal Factors” and 7 suggested modifications were generated to capture important disease-specific qualities not elsewhere described in ICF, e.g. “pf_embarrassed by cough”; “pf_panic/afraid when can't get breath”; pf_fear of hurting self by overexertion; d4508_walking pace or b469_bouts of coughing to describe paroxysmal coughing spells that are often disabling in this condition.

Conclusions This is the first effort to map CTD-ILD and IPF outcome measures to the ICF. ICF Core Sets provide stream-lined disease-specific coding of disability data that support global, regional and personal health-related parity across cultures, age and socioeconomic status; enabling fair assessment of disability for policy-making, service provision, funding and rural/urban infrastructural modifications. Validation steps are planned for item analysis and potential development of a single composite instrument for clinical trials and clinical practice.

The availability of ICF Core Sets in CTD-ILD and IPF will afford clinicians a smoother transition to ICD-11 which is under development and will meld diagnostic coding with the ICF.

Disclosure of Interest L. A. Saketkoo Grant/research support from: ACR/EULAR Exchange Awardee, R. Escorpizo: None declared, K. Keen: None declared, K. Fligelstone: None declared, S. Birring: None declared, M. Lammi: None declared, J. Lasky: None declared, D. LeSage: None declared, E. Renzoni: None declared, A. M. Russell: None declared, C. Sarver: None declared, M. B. Scholand: None declared, J. Varga: None declared, O. Distler: None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.